Corrigendum to "SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo" [Cancer Lett. 351 (2014) 143–50]. (28th August 2020) - Wang, Lu; Ai, Jing; Shen, Yanyan; Zhang, Haotian; Peng, Xia; Huang, Min; Zhang, Ao; Ding, Jian; Geng, Meiyu